German drugmaker Stada will launch a product that will diagnose Ebola virus infection in a few months next month. The company announced the news on the 9th, hoping that this will help slow the spread of the disease.
This diagnostic product was developed and produced by an unlisted German diagnostic product company and sold. It produces results based on pre-treated patient blood samples in approximately 10 minutes.
Stada said that its main use is likely to diagnose the dead because their body fluids do not require pre-test pretreatment. Contact with the deceased during the mourning of relatives is also a common form of disease transmission.
Senova's boss, Soeffing, points out that patients with Ebola virus death have very high viral loads, and even with a swab, they can be quickly tested.
Last week, the number of newly discovered Ebola cases in the three most affected countries in West Africa rose sharply, and the World Health Organization (WHO) said it reversed the decline in the number of cases in the region.
According to the World Health Organization, since the outbreak of Ebola in nine countries in December, 8,981 people have died of Ebola virus infection and 22,495 have been confirmed.
A spokesperson for Stada said that its diagnostic products are used for living patients, often requiring pre-treated blood samples and powered centrifuges, which are available in emergency rescue centers in affected areas.
Stada, a supplier of generic, over-the-counter drugs and diagnostics, said it will distribute diagnostics to aid organizations next month at a cost price of 3.20 euros per person.
According to company news, the diagnostic product has proven effective in trials involving hundreds of people in Guinea. Although Stada claims that the diagnostic reagent is the first of its kind, there have been similar products that speed up the diagnosis of Ebola virus. The health charity Wellcome Trust said in November that a new Ebola 15-minute test reagent supported by the fund is being tested in Guinea, six times faster than current diagnostic kits.